Refine your search

Search Results

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

1 Study Matches

A Phase 3 Efficacy and Safety Study of Tapinarof for the Treatment of Moderate to Severe Atopic Dermatitis in Children and Adults

Atopic Dermatitis: Phase 3 double-blinded study, 8 week study with potential rollover into an open label extension. Topical cream. Males/females 2 years and above with atopic dermatitis (AD) Atopic Dermatitis (AD), also known as eczema, is an inflammatory skin condition that can occur repeatedly. AD often causes itching and burning, skin flaking, and red bumps that can crust and open up. The purpose of this study is to find out if the study medicine, tapinarof cream, can help with the treatment of AD.
Samantha Gettle at sgettle2@pennstatehealth.psu.edu or 717-531-5136
All
All
This study is NOT accepting healthy volunteers
NCT05014568
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
AD present for at least 6 months for ages 6 and above, or 3 months for ages 2 to 5
AD covering between 5% and 35% body surface area
Willing to follow all study guidelines
Exclusion Criteria:
Positive test results for HIV
Current or chronic liver disease
Certain treatments for AD are not allowed; coordinator will discuss specific treatments
Skin Conditions
  Email this study information to me
  Contact the study team
  See more information
  Show all 1 locations

Study Locations

Hide all locations
Location
Hershey, PA